 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 10/26/2016 |
$41.15 |
$41.50 |
$41.08 |
$41.33 |
568.80K | | 10/27/2016 |
$41.50 |
$41.93 |
$41.27 |
$41.50 |
159.30K | | 10/28/2016 |
$41.57 |
$41.82 |
$41.26 |
$41.82 |
234.20K | | 10/31/2016 |
$41.83 |
$42.33 |
$40.39 |
$42.09 |
521.40K | | 11/01/2016 |
$42.09 |
$42.09 |
$42.09 |
$42.09 |
0 |
|
|
| Tobira Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies to treat liver disease, inflammation, fibrosis and human immunodeficiency virus (HIV). Co.'s product candidate, cenicriviroc (CVC), is an immunomodulator and dual inhibitor of CCR2 and CCR5 being evaluated for the treatment of non-alcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC), and as an adjunctive therapy to standard of care in HIV. Co. operates in one reportable segment in the U.S. of America. CVC is an oral, once-daily, potent immunomodulator with a binding affinity. NASH is a severe type of non-alcoholic fatty liver disease. | |
|
TBRA (TBRA) has the following price history information. Looking back at TBRA historical stock prices for the last five trading days, on October 26, 2016, TBRA opened at $41.15, traded as high as $41.50 and as low as $41.08, and closed at $41.33. Trading volume was a total of 568.80K shares. On October 27, 2016, TBRA opened at $41.50, traded as high as $41.93 and as low as $41.27, and closed at $41.50. Trading volume was a total of 159.30K shares. On October 28, 2016, TBRA opened at $41.57, traded as high as $41.82 and as low as $41.26, and closed at $41.82. Trading volume was a total of 234.20K shares. On October 31, 2016, TBRA opened at $41.83, traded as high as $42.33 and as low as $40.39, and closed at $42.09. Trading volume was a total of 521.40K shares. On November 01, 2016, TBRA opened at $42.09, traded as high as $42.09 and as low as $42.09, and closed at $42.09. Trading volume was a total of 0 shares.
TBRA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into TBRA shares, starting with a $10,000 purchase of TBRA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
11/01/2016 |
|
| Start price/share: |
$65.43 |
|
| End price/share: |
$42.09 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-35.67% |
|
| Average Annual Total Return: |
-15.99% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6,433.44 |
|
| Years: |
2.53 |
|
|
|
| Date |
Close |
| 10/26/2016 | $41.33 | | 10/27/2016 | $41.50 | | 10/28/2016 | $41.82 | | 10/31/2016 | $42.09 | | 11/01/2016 | $42.09 |
|
|
Free TBRA Email Alerts:
